CONCENTRA GROUP HOLDINGS PARENT, INC. vs NATIONAL HEALTHCARE CORP, two Medical Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Concentra's 16.8% operating margin doubles National HealthCare's 8.5%, occupational-health clinics out-earning skilled nursing on every visit, and the leverage triples the contrast: Concentra runs at 3.62 turns of debt from its spinoff, NHC at zero. The geared margin machine earns a 41.2% return on equity that the 6.2% return on assets deflates to honest size; NHC's 11.3% and 8.1% need no adjustment. The multiples sit close, 21.7 and 25.5 times, with the premium on the unlevered slow one. Free-cash yields match near 5.3-5.5%, dividends near 0.8-1.3%. The pair prices a choice between margin with debt and modesty without; the market has quietly picked modesty.
Comparison updated 2026-07-10.
| Metric | CON | NHC |
|---|---|---|
| Price | $30.16 | $200.71 |
| Market cap | $3.9B | $3.2B |
| Sector | Medical Care | Medical Care |
| Stage | Growth | Mature |
| Implied growth (priced in) | -4.1% | +13.2% |
| P/E | 21.7 | 25.5 |
| P/B | 8.97 | 2.89 |
| P/S | 1.74 | 2.07 |
| EV/EBITDA | 12.6 | 17.6 |
| Revenue growth | +15.5% | +11.0% |
| Operating margin | 16.8% | 8.4% |
| Net margin | 8.0% | 8.1% |
| Return on equity | 41.2% | 11.3% |
| Return on assets | 6.2% | 8.1% |
| Return on invested capital | 13.2% | 9.5% |
| FCF yield | 5.5% | 5.3% |
| Dividend yield | 0.8% | 1.3% |
| Debt / equity | 3.62 | 0.00 |
| Current ratio | 1.26 | 1.86 |
| Altman Z (solvency) | 1.96 | 6.47 |
| Piotroski F (quality) | 7 / 9 | 6 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.